Fundamental understanding of drug absorption from a parenteral oil depot

European Journal of Pharmaceutical Sciences

Volumn 83, Issue , 2016, Pages 19-27

  Kalicharan, Raween W ^a,b   Schot, Peter ^c   Vromans, Herman ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c OrgaNext Research BV   (Netherlands)

Author keywords

Absorbance; Benzyl alcohol; Nandrolone; Oil depots; Pharmacokinetics

Indexed keywords

BENZYL ALCOHOL; HALOPERIDOL DECANOATE; NANDROLONE DECANOATE; NANDROLONE PHENPROPIONATE; OIL; PRODRUG; ANDROGEN; DRUG DOSAGE FORM; NANDROLONE; SESAME SEED OIL;

ABSENCE OF SIDE EFFECTS; ABSORPTION LAG TIME; ABSORPTION RATE CONSTANT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG FORMULATION; ELIMINATION RATE CONSTANT; FEMALE; HUMAN; HUMAN EXPERIMENT; LYMPH VESSEL; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SERUM; SUSTAINED RELEASE FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY; VOLUME OF DISTRIBUTION; ABSORPTION; ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; DRUG DOSAGE FORM; INTRAMUSCULAR DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; VERY ELDERLY;

ABSORPTION, PHYSIOLOGICAL; AGED; AGED, 80 AND OVER; ANDROGENS; BENZYL ALCOHOL; DOSAGE FORMS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; NANDROLONE; SESAME OIL; VISCOSITY;

EID: 84950258562     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.12.011     Document Type: Article

References (38)

1. A. Andrés, M. Rosés, C. Ràfols, E. Bosch, S. Espinosa, V. Segarra, and J.M. Huerta Setup and validation of shake-flask procedures for the determination of partition coefficients (logD) from low drug amounts Eur. J. Pharm. Sci. 76 2015 181 191 10.1016/j.ejps.2015.05.008
2. C. Bach, and G.P. Lewis Lymph flow and lymph protein concentration in the skin and muscle of the rabbit hind limb J. Physiol. 235 1973 477 492
3. W.M. Bagchus, J.M.W. Smeets, H.A.M. Verheul, S.M. De Jager-Van Der Veen, A. Port, and T.B.P. Geurts Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men J. Clin. Endocrinol. Metab. 90 2005 2624 2630 10.1210/jc.2004-1526
4. ChemSpider [WWW Document] URL http://www.chemspider.com 2015
5. E.F. Evans, J.D. Proctor, M.J. Fratkin, J. Velandia, and A.J. Wasserman Blood flow in muscle groups and drug absorption Clin. Pharmacol. Ther. 17 1975 44 47 10.1097/00132586-197602000-00010
6. E. Havas, T. Parviainen, J. Vuorela, J. Toivanen, T. Nikula, and V. Vihko Lymph flow dynamics in exercising human skeletal muscle as detected by scintography J. Physiol. 504 1997 233 239 10.1111/j.1469-7793.1997.233bf.x
7. F. Ikomi, J. Hunt, G. Hanna, G.W. Schmid-schönbein, A. Szuba, W.S. Shin, H.W. Strauss, S. Rockson, and G.W. Schmid-scho Interstitial fluid, plasma protein, colloid, and leukocyte uptake into initial lymphatics Interstitial fluid, plasma protein, colloid, and leukocyte uptake into initial lymphatics 2060-2067 2014
8. M.W. Jann, L. Ereshefsky, and S.R. Saklad Clinical pharmacokinetics of the depot antipsychotics Clin. Pharmacokinet. 10 1985 315 333 10.2165/00003088-198510040-00003
9. F. Kadir, C.B.J. Seijsener, and J. Zuidema Influence of the injection volume on the release pattern of intramuscularly administered propranolol to rats Int. J. Pharm. 81 1992 193 198 10.1016/0378-5173(92)90011-P
10. F. Kadir, J. Zuidema, A. Pijpers, A. Vulto, and J.H.M. Verheijden Drug lipophilicity and release pattern of some β-blocking agents after intra-adipose injection in pigs Int. J. Pharm. 64 1990 171 180 10.1016/0378-5173(90)90266-7
11. S. Kudo, and T. Ishizaki Pharmacokinetics of haloperidol: an update Clin. Pharmacokinet. 37 1999 435 456
12. S.W. Larsen, J. Østergaard, H. Friberg-Johansen, M.N.B. Jessen, and C. Larsen In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration Eur. J. Pharm. Sci. 29 2006 348 354 10.1016/j.ejps.2006.07.002
13. C.F. Minto, C. Howe, S. Wishart, A.J. Conway, and D.J. Handelsman Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume J. Pharmacol. Exp. Ther. 281 1997 93 102
14. A.C. Moffat, M.D. Osselton, B. Widdop, and J. Watts Clarke's Analysis of Drugs and Poisons fourth ed. 2003 Pharmaceutical Press London 10.1080/00450618.2011.620006
15. A. Morgentaler, A.S. Dobs, J.M. Kaufman, M.M. Miner, R. Shabsigh, R.S. Swerdloff, and C. Wang Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study J. Urol. 180 2008 2307 2313 10.1016/j.juro.2008.08.126
16. D. O'Hagan, N. Christy, and S. Davis Particulates and lymphatic drug delivery Lymphatic Transport of Drugs 1992 CRC Press 352
17. W. Olszewski Peripheral Lymph: Formation and Immune Function 1985 CRC Press
18. W.L. Olszewski, and A. Engeset Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg Am. J. Physiol. 239 1980 H775 H783
19. M.J. O'Neil, P.E. Heckelman, C.B. Koch, and K.J. Roman The Merck Index: An Encyclopedia of Chemicals Fourteenth. ed. 2006 Merck & Co. Inc. New Jersy
20. C.J.H. Porter, and S.A. Charman Lymphatic transport of proteins after subcutaneous administration J. Pharm. Sci. 89 2000 297 310 10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P
21. C.J.H. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248 10.1038/nrd2197
22. E. Renkin, and H. Wiig Limits to steady-state lymph flow rates derived from plasma-to-tissue uptake measurements Microvasc. Res. 47 1994 318 328
23. A. Ronald, D. Docherty, J. Broom, and W. Chambers Subarachnoid local anesthetic block does not affect morphine absorption from paired intramuscular and subcutaneous injection sites in the elderly patient Anesth. Analg. 76 1993 778 782 10.1213/00000539-199304000-00016
24. R.C.R. Rowe, P.J.S. Sheskey, and W. Cook Handbook Pharmaceutical Excipients 2009 Pharmaceutical Press London (Sixth Edition, Seventh ed. Ed.)
25. S.M. Soni, D. Wiles, A.A. Schiff, and J.S. Bamrah Plasma levels of fluphenazine decanoate: effects of site of injection, massage and muscle activity Br. J. Psychiatry 153 1988 382 384 10.1192/bjp.153.3.382
26. M.A. Swartz, and M.E. Fleury Interstitial flow and its effects in soft tissues Annu. Rev. Biomed. Eng. 9 2007 229 256 10.1146/annurev.bioeng.9.060906.151850
27. T. Tanaka, H. Kobayashi, K. Okumura, S. Muranishi, and H. Sezaki Intramuscular absorption of drugs from oily solutions in the rat Chem. Pharm. Bull. (Tokyo) 22 1974 1275 1284 10.1248/cpb.22.1275
28. M. Thing, C. Larsen, J. Østergaard, H. Jensen, and S.W. Larsen In vitro release from oil injectables for intra-articular administration: importance of interfacial area, diffusivity and partitioning Eur. J. Pharm. Sci. 45 2012 351 357 10.1016/j.ejps.2011.12.006
29. J. Van Der Vies Model studies in vitro with long-acting hormonal preparations Acta Endocrinol. (Copenh) 64 1970 656 669 10.1530/acta.0.0640656
30. G. Van Weringh, B.J. Komen, R.E. Thieme, R.T.M. van der Hoeven, and T. Vos Comparative bioavailability study of two haloperidol decanoate containing products Pharm. World Sci. 16 1994 343 347 10.1007/BF02178564
31. R.A. Vukovich, L.J. Brannick, A.A. Sugerman, and E.S. Neiss Sex differences in the intramuscular absorption and bioavailability of cephradine Clin. Pharmacol. Ther. 18 1975 215 220
32. J.G. Wagner Application of the Wagner-Nelson absorption method to the two-compartment open model J. Pharmacokinet. Biopharm. 2 1974 469 486 10.1007/BF01070942
33. S. Weng Larsen, and C. Larsen Critical factors influencing the in vivo performance of long-acting lipophilic solutions - impact on in vitro release method design AAPS J. 11 2009 762 770 10.1208/s12248-009-9153-9
34. C.M. White, M.J. Ferraro-Borgida, N.M. Moyna, C.C. McGill, A.W. Ahlberg, P.D. Thompson, and G.V. Heller The effect of pharmacokinetically guided acute intravenous testosterone administration on electrocardiographic and blood pressure variables J. Clin. Pharmacol. 39 1999 1038 1043 10.1177/00912709922011809
35. H.P. Wijnand, A.M. Bosch, and C.W. Donker Pharmacokinetic parameters of nandrolone (19-nortestosterone) after intramuscular administration of nandrolone decanoate (Deca-Durabolin) to healthy volunteers Acta Endocrinol. Suppl. (Copenh) 271 1985 19 30 10.1530/acta.0.109S00019
36. J.A. Yáñez, C.M. Remsberg, C.L. Sayre, M.L. Forrest, and N.M. Davies Flip-flop pharmacokinetics - delivering a reversal of disposition: challenges and opportunities during drug development Ther. Deliv. 2 2011 643 672 10.4155/tde.11.19
37. J. Zuidema, F. Kadir, H.A.C. Titulaer, and C. Oussoren Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II) Int. J. Pharm. 105 1994 189 207 10.1016/0378-5173(94)90103-1
38. J. Zuidema, F.A.J.M. Pieters, and G.S.M.J.E. Duchateau Release and absorption rate aspects of intramuscularly injected pharmaceuticals Int. J. Pharm. 47 1988 1 12 10.1016/0378-5173(88)90209-8